Recurrent Thyroid Gland Medullary Carcinoma
4 clinical trials · Condition
◉ Watch Recurrent Thyroid Gland Medullary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| GFRα4 CAR T Cells in MTC Patients (NCT04877613) | University of Pennsylvania | 2021-08-19 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer (NCT00390325) | National Cancer Institute (NCI) | 2006-11-03 |
Track Recurrent Thyroid Gland Medullary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.